Yoshida et al.
solution of 3 (1.06 g, 2.32 mmol) in ethanol/THF (4/1) (20 mL).
The mixture was stirred for 4 h at 70 °C. A yellow precipitate
was obtained by adjusting the pH of the mixture to ∼3 by
adding concentrated aqueous HCl. Recrystallization of the
precipitate from THF/H2O (4/1) gave 4 as yellow needles (850
mg, 1.98 mmol, 86%): mp 221-225 °C; IR (KBr) 3000, 1680;
1H NMR (500 MHz, DMSO-d6) δ 4.90 (4H, s), 5.51 (2H, s), 7.40
(2H, t, J ) 7.6), 7.47 (2H, s), 7.53 (2H, t, J ) 7.6), 7.80 (2H, d,
J ) 8.2), 7.94 (2H, d, J ) 8.1), 8.27 (2H, s), 12.96 (2H, s). Anal.
Calcd for C26H20O6: C, 72.89; H, 4.71. Found: C, 72.73; H,
4.97.
(R,R)-N-1-P h en yleth yl 2-[[2-[2-[3-(N-1-p h en yleth ylca r -
bam oyl)n aph th oxy]m eth yl]allyl]oxy]-3-n aph th oic Am ide
((R,R)-5g). (R,R)-5g was obtained from 4 (860 mg, 2.01 mmol)
and R-R-phenylethylamine (484 mg, 3.99 mmol) as a white
solid (1.17 g, 1.84 mmol, 92%).
Syn th esis of Ma cr ocyclic Na p h th ol 6. Compound char-
acterization data for 6b-g are listed in the Supporting
Information.
Ma cr ocyclic Na p h th ol 6a . 5a (150 mg, 0.331 mmol) was
dissolved in N,N-dimethylaniline (5 mL) at 150 °C. The
solution was heated at 180 °C for 2 h to afford a yellow
precipitate. The precipitate was collected by filtration and
washed with CH2Cl2 to give 6a (30 mg, 0.066 mmol, 20%) as
a yellow powder: mp 325-326 °C; IR (KBr) 3320, 1640; 1H
NMR (300 MHz, DMSO-d6) δ 3.14 (2H, d, J ) 7.8), 3.38 (2H,
d, J ) 16.8), 3.70 (2H, d, J ) 15.6), 4.15 (2H, s), 5.43 (2H, s),
7.31 (2H, t, J ) 7.8), 7.50 (2H, t, J ) 7.7), 7.80 (2H, d, J )
8.1), 8.02 (2H, d, J ) 8.4), 8.20 (2H, s), 8.82 (2H, s), 11.35 (2H,
s). Anal. Calcd for C28H24N2O4: C, 74.32; H, 5.35; N, 6.19.
Found: C, 74.55; H, 5.46; N, 6.15.
Ma cr ocyclic Na p h th ol (R,R)-6b. (R,R)-5b (70 mg, 0.116
mmol) was melted at 220 °C by using a glass tube oven
equipped with a vacuum pump. The melt was heated at 180
°C for 1 h. Purification by PTLC (CHCl3×2) gave (R,R)-6b (43
mg, 0.071 mmol, 60%) as a yellow solid. A crystal suitable for
X-ray analysis was obtained from a CH2Cl2 solution by the
vapor diffusion method.
Syn th esis of Ma cr ocycle 5. The synthetic procedure for
5a is representative for the preparation of all the other
compounds 5. Compound characterization data for 5b-g are
listed in the Supporting Information.
Ma cr ocycle 5a . To a suspension of 4 (1.71 g, 4.00 mmol)
in benzene (40 mL) was added thionyl chloride (9.5 g, 80 mmol)
at rt. The mixture was stirred for 10 h at 60 °C to afford a
yellow solution. The solution was concentrated under reduced
pressure to give a yellow solid that was dried under vacuum
at 60 °C. After the solid had been dissolved in benzene (200
mL), triethylamine (1.6 g, 16 mmol) was added at rt. Ethyl-
enediamine (240 mg, 4.00 mmol) in benzene (200 mL) was
added dropwise over 2 h at 50 °C to this solution. After being
stirred for an additional 2 h, the mixture was concentrated
under reduced pressure and then extracted with CH2Cl2. After
the usual workup, 5a was obtained as a white solid (873 mg,
1.70 mmol, 43%): mp 209-211 °C; IR (KBr) 3400, 1640; 1H
NMR (300 MHz, CDCl3) δ 3.83 (4H, dd, J ) 2.9, 3.0), 4.88 (4H,
s), 5.78(2H, s), 7.25 (2H, s), 7.42 (2H, t, J ) 7.7), 7.53 (2H, t,
J ) 7.5), 7.72 (2H, d, J ) 8.1), 7.92 (2H, d, J ) 8.1), 8.29 (2H,
s), 8.77 (2H,s). Anal. Calcd for C28H24N2O4: C, 74.32; H, 5.35;
N, 6.19. Found: C, 74.17; H, 5.32; N, 6.12.
Ma cr ocyclic Na p h th ol (S,S)-6b. (S,S)-5b (75 mg, 0.124
mmol) was melted at 220 °C by using a glass tube oven
equipped with a vacuum pump. The melt was heated at 180
°C for 1 h. Purification by PTLC (CHCl3 × 2) gave (S,S)-6b
(60 mg, 0.099 mmol, 80%) as a yellow solid.
Ma cr ocyclic Na p h th ol (R,R)-6c. According to the proce-
dure given for the preparation of 6a , (R,R)-6c was obtained
from (R,R)-5c (150 mg, 0.296 mmol) as a yellow solid (93 mg,
0.184 mmol, 62%) after purification by PTLC (CHCl3). A crystal
Ma cr ocycle (R,R)-5b. (R,R)-5b was obtained from 4 (428
mg, 1.00 mmol) and (1R,2R)-diphenylethylenediamine (212
mg, 1.00 mmol) as a white solid (182 mg, 0.301 mmol, 30%)
after purification by PTLC (CHCl3 × 5).
suitable for X-ray analysis was obtained from
solution.
a DMSO
Ma cr ocycle (S,S)-5b. (S,S)-5b was obtained from 4 (435
mg, 1.01 mmol) and (1S,2S)-diphenylethylenediamine (214 mg,
1.01 mmol) as a white solid (234 mg, 0.387 mmol, 38%) after
purification by PTLC (CHCl3 × 5).
Ma cr ocyclic Na p h th ol (S,S)-6c. According to the proce-
dure given for the preparation of 6a , (S,S)-6c was obtained
from (S,S)-5c (116 mg, 0.228 mmol) as a yellow solid (64 mg,
0.126 mmol, 55%) after purification by PTLC (CHCl3).
Ma cr ocyclic Na p h th ol 6d . According to the procedure
given for the preparation of 6a , 6d was obtained from 5d (123
mg, 0.243 mmol) as a yellow solid (39 mg, 0.077 mmol, 32%)
after purification by PTLC (CHCl3×2). A crystal suitable for
X-ray analysis was obtained from a DMSO solution.
Ma cr ocyclic Na p h th ol (S,S)-6e. (S,S)-5e (51 mg, 0.092
mmol) was heated at 160 °C for 2 h by using a glass tube oven
equipped with a vacuum pump. Purification by PTLC (CHCl3/
ethyl acetate (2/1) × 2) gave (S,S)-6e (45 mg, 0.081 mmol, 88%)
as a yellow solid. A crystal suitable for X-ray analysis was
obtained from a DMSO solution.
Ma cr ocycle (R,R)-5c. (R,R)-5c was obtained from 4 (857
mg, 2.00 mmol) and (1R,2R)-1,2-cyclohexanediamine (228 mg,
2.00 mmol) as a white solid (300 mg, 0.592 mmol, 30%) after
purification by column chromatography (CHCl3).
Ma cr ocycle (S,S)-5c. (S,S)-5c was obtained from 4 (233
mg, 0.544 mmol) and (1S,2S)-1,2-cyclohexanediamine (62 mg,
0.543 mmol) as a white solid (95 mg, 0.189 mmol, 35%) after
purification by column chromatography (CHCl3).
Ma cr ocycle 5d . 5d was obtained from 4 (857 mg, 2.00
mmol) and cis-1,2-cyclohexanediamine (228 mg, 2.00 mmol)
as a white foam (666 mg, 1.31 mmol, 66%) after purification
by column chromatography (CHCl3).
Ma cr ocyclic Na p h th ol 6f. According to the procedure
given for the preparation of (S,S)-6e, 6f was obtained from 5f
(63 mg, 0.127 mmol) as a yellow solid (27 mg, 0.055 mmol,
43%) after purification by PTLC (CHCl3 × 3). A crystal suitable
for X-ray analysis was obtained from a CH2Cl2 solution.
(R,R)-N-1-P h en yleth yl-2-h yd r oxy-1-[2-[1-[2-h yd r oxy-3-
(N-1-p h en ylet h ylca r b a m oyl)n a p h t h yl]m et h yl]a llyl]-3-
n a p h th oic Am id e ((R,R)-6g). According to the procedure
given for the preparation of (S,S)-6e, (R,R)-6g was obtained
from (R,R)-5g (153 mg, 0.241 mmol) as a yellow solid (104 mg,
0.164 mmol, 68%) after purification by PTLC (benzene/ethyl
acetate (95/5) × 3).
Ma cr ocycle (S,S)-5e. (S,S)-5e was obtained from 4 (857
mg, 2.00 mmol) and (2S,3S)-2,3-isopropylidenedioxy-1,4-bu-
tanediamine (320 mg, 2.00 mmol), which was prepared ac-
cording to the literature methods,14-16 as a white foam (580
mg, 1.05 mmol, 52%) after purification by column chromatog-
raphy (CHCl3/ethyl acetate (4/1)).
Ma cr ocycle 5f. 5f was obtained from 4 (857 mg, 2.00 mmol)
and 2,2-dimethyl-1,3-propanediamine (204 mg, 2.00 mmol) as
a white foam (821 mg, 1.65 mmol, 83%) after purification by
column chromatography (CHCl3).
(13) Zijlstra, R. W. J .; J ager, W. F.; Lange, Ben.; Duijnen, P.;
Feringa, Ben. L.; Goto, H.; Saito, A.; Koumura, N.; Harada, N. J . Org.
Chem. 1999, 64, 1667-1674.
(14) Reduction of tartaricamide: Haines, A. H.; Morley, C.; Murrer,
B. A. J . Med. Chem. 1989, 32, 742-745.
(15) Isopropyridenation of tartaric acid: Mash, E. A.; Nelson, K. A.;
Van Deusen, S.; Hemperly, S. B. Org. Synth. 1990, 68, 92-103.
(16) Amidation of tartaric acid: Carroll, F. I. J . Org. Chem. 1966,
31, 366-368.
Su p p or tin g In for m a tion Ava ila ble: Crystallographic
data for (R,R)-6b, (R,R)-6c, 6d , (S,S)-6e, and 6f, compound
characterization data for 5b-g and 6b-g, and 1H NMR
spectra of all new compounds. This material is available free
J O0340298
5818 J . Org. Chem., Vol. 68, No. 15, 2003